Showing results (211-220 of 285) with videos related to

Sort By:
Pageof 29
The Journal of Pathology|June 8, 2010
In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis CTarik Asselah, Ivan Bièche, Abdellah Mansouri, et al.
The New England Journal of Medicine|July 1, 2005
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis BGeorge K K Lau, Teerha Piratvisuth, Kang Xian Luo, et al.
Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis BPatrick Marcellin, Herve Mommeja-Marin, Stephen L Sacks, et al.
Cytokine|March 12, 2002
Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapyManuela G Neuman, Jean-Pierre Benhamou, Marc Bourliere, et al.
JHEP Reports : Innovation in Hepatology|March 13, 2023
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cellsAbhishek Aggarwal, Pamela M Odorizzi, Jens Brodbeck, et al.
Hepatology (Baltimore, Md.)|May 13, 2015
Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trialsSaleh A Alqahtani, Nezam Afdhal, Stefan Zeuzem, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patientsCédric Laouénan, Patrick Marcellin, Martine Lapalus, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2019
Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infectionPatrick Marcellin, David K Wong, William Sievert, et al.
Pageof 29